Steve O'Loughlin
Equibles does not estimate personal net worth.
Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNSP alertsAbout Steve O'Loughlin
Steve O'Loughlin is recorded as CFO at CNS Pharmaceuticals, Inc. (CNSP) since March 2, 2026. The newest filing on record that lists Steve O'Loughlin as CFO at CNS Pharmaceuticals, Inc. (CNSP) is dated August 21, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed February 17, 2026 that Steve O'Loughlin was appointed Chief Financial Officer, effective March 2, 2026. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Rami Levin (CEO and Board Member), Faith Charles (Chairman and Board Member), Eric Faulkner (CTO) and 7 others.
“On February 10, 2026, CNS Pharmaceuticals, Inc. (the “Company”) entered into an employment agreement (the “O’Loughlin Employment Agreement”) with Steve O’Loughlin to serve as the Company’s Chief Financial Officer effective March 2, 2026.”
Affiliation history
-
Current
2026-03-02–present
Last confirmed August 21, 2026
Company network
Leadership on record at CNS Pharmaceuticals, Inc.
- Rami Levin CEO, Board Member
- Faith Charles Chairman, Board Member
- Eric Faulkner CTO
- Amy Mahery Board Member
- Bettina Cockroft Board Member
- Bettina M. Cockroft, M.D., M.B.A. Board Member
- Faith L. Charles Board Member
- Jeff Keyes Board Member
- Jeffrey Keyes Board Member
- Jeffry R. Keyes Board Member